Andrea Paradisi

Dr. Andrea Paradisi

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2006 in Cell Death & Differentiation
Verified
Journal Article
Closed access
ECE Candi
E Candi
ARA Rufini
A Rufini
Alessandro TerrinoniAlessandro Terrinoni
Alessandro Terrinoni
DDD Dinsdale
D Dinsdale
MRM Ranalli
M Ranalli
GMGerry Melino
Gerry Melino

1 October 2005 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
Mauro MaccarroneMauro Maccarrone
Mauro Maccarrone
BBBarbara Barboni
Barbara Barboni
APAndrea Paradisi
Andrea Paradisi
Nicola BernabòNicola Bernabò
Nicola Bernabò
VGValeria Gasperi
Valeria Gasperi
MMMauro Mattioli
Mauro Mattioli
Anandamide (AEA) is the endogenous ligand of cannabinoid (CB) receptors, and as such it plays several central and peripheral activities. Regulation of female fertility by AEA has attracted growing interest, yet a role for this endocannabinoid in controlling sperm function and male fertility in mammals has been scarcely investigated. In this study we report unprecedented evidence that boar sperm cells have the biochemical machinery to bind and degrade AEA, i.e. type-1 cannabinoid receptors (CB1R), vanilloid receptors (TRPV1), AEA-synthesizing phospholipase D (NAPE-PLD), AEA transporter (AMT) and AEA hydrolase (FAAH). We also show that the non-hydrolyzable AEA analogue methanandamide reduces sperm capacitation and, as a consequence, inhibits the process of acrosome reaction (AR) triggered by the zona pellucida, according to a cyclic AMP-dependent pathway triggered by CB1R activation. Furthermore, activation of TRPV1 receptors seems to play a role of stabilization of the plasma membranes in capacitated sperm, as demonstrated by the high incidence of spontaneous AR occurring during the cultural period when TRPV1 activity was antagonized by capsazepine. We show that sperm cells have a complete and efficient endocannabinoid system, and that activation of cannabinoid or vanilloid receptors controls, at different time-points, sperm functions required for fertilization. These observations open new perspectives on the understanding and treatment of male fertility problems.

2 August 2023 in Nature
Verified
Journal Article
Open access
PDF file
PCPhilippe A. Cassier
Philippe A. Cassier
RNRaul Navaridas
Raul Navaridas
MBMelanie Bellina
Melanie Bellina
NRNicolas Rama
Nicolas Rama
BDBenjamin Ducarouge
Benjamin Ducarouge
PMPatrick Mehlen
Patrick Mehlen
Netrin-1 is upregulated in cancers as a protumoural mechanism1. Here we describe netrin-1 upregulation in a majority of human endometrial carcinomas (ECs) and demonstrate that netrin-1 blockade, using an anti-netrin-1 antibody (NP137), is effective in reduction of tumour progression in an EC mouse model. We next examined the efficacy of NP137, as a first-in-class single agent, in a Phase I trial comprising 14 patients with advanced EC. As best response we observed 8 stable disease (8 out of 14, 57.1%) and 1 objective response as RECIST v.1.1 (partial response, 1 out of 14 (7.1%), 51.16% reduction in target lesions at 6 weeks and up to 54.65% reduction during the following 6 months). To evaluate the NP137 mechanism of action, mouse tumour gene profiling was performed, and we observed, in addition to cell death induction, that NP137 inhibited epithelial-to-mesenchymal transition (EMT). By performing bulk RNA sequencing (RNA-seq), spatial transcriptomics and single-cell RNA-seq on paired pre- and on-treatment biopsies from patients with EC from the NP137 trial, we noted a net reduction in tumour EMT. This was associated with changes in immune infiltrate and increased interactions between cancer cells and the tumour microenvironment. Given the importance of EMT in resistance to current standards of care2, we show in the EC mouse model that a combination of NP137 with carboplatin-paclitaxel outperformed carboplatin-paclitaxel alone. Our results identify netrin-1 blockade as a clinical strategy triggering both tumour debulking and EMT inhibition, thus potentially alleviating resistance to standard treatments.

6 April 2009 in Journal of Experimental Medicine
Verified
Journal Article
Open access
CDCéline Delloye-Bourgeois
Céline Delloye-Bourgeois
JFJulien Fitamant
Julien Fitamant
APAndrea Paradisi
Andrea Paradisi
DCDavid Cappellen
David Cappellen
SDSetha Douc-Rasy
Setha Douc-Rasy
PMPatrick Mehlen
Patrick Mehlen
Neuroblastoma (NB), the most frequent solid tumor of early childhood, is diagnosed as a disseminated disease in >60% of cases, and several lines of evidence support the resistance to apoptosis as a prerequisite for NB progression. We show that autocrine production of netrin-1, a multifunctional laminin-related molecule, conveys a selective advantage in tumor growth and dissemination in aggressive NB, as it blocks the proapoptotic activity of the UNC5H netrin-1 dependence receptors. We show that such netrin-1 up-regulation is a potential marker for poor prognosis in stage 4S and, more generally, in NB stage 4 diagnosed infants. Moreover, we propose that interference with the netrin-1 autocrine loop in malignant neuroblasts could represent an alternative therapeutic strategy, as disruption of this loop triggers in vitro NB cell death and inhibits NB metastasis in avian and mouse models.

6 October 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
APAndrea Paradisi
Andrea Paradisi
CMCarine Maisse
Carine Maisse
MCMarie-May Coissieux
Marie-May Coissieux
NGNicolas Gadot
Nicolas Gadot
FLFlorian Lépinasse
Florian Lépinasse
PMPatrick Mehlen
Patrick Mehlen
Chronic inflammation and cancer are intimately associated. This is particularly true for inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease, which show a major increased risk for colorectal cancer. While the understanding of the molecular pathogenesis of IBD has recently improved, the mechanisms that link these chronic inflammatory states to colorectal cancer development are in large part unknown. One of these mechanisms is NF-κB pathway activation which in turn may contribute to tumor formation by providing anti-apoptotic survival signals to the epithelial cells. Based on the observation that netrin-1, the anti-apoptotic ligand for the dependence receptors DCC and UNC5H is up-regulated in colonic crypts in response to NF-κB, we show here that colorectal cancers from inflammatory bowel diseases patients have selected up-regulation of netrin-1. Moreover, we demonstrate that this inflammation-driven netrin-1 up-regulation is causal for colorectal cancer development as interference with netrin-1 autocrine loop in a mouse model for ulcerative colitis-associated colorectal cancer, while showing no effect on inflammation, inhibits colorectal cancer progression.

1 October 2008 in Gastroenterology
Verified
Journal Article
Closed access
APAndrea Paradisi
Andrea Paradisi
CMCarine Maisse
Carine Maisse
ABAgnès Bernet
Agnès Bernet
MCMarie–May Coissieux
Marie–May Coissieux
MMMauro Maccarrone
Mauro Maccarrone
PMPatrick Mehlen
Patrick Mehlen